Mark Chang (Internal Medicine) and colleagues published the article, "Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinome," in European Urology Oncology.
Mark Chang (Internal Medicine) and colleagues published the article, "Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinome," in European Urology Oncology.